フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s...
Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s...
Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization...
Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and...
Mithra reports full year 2023 financial results Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from...
Mithra announces changes to its executive management Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 –...
Mithra initiates monetization process, receives bridge loan from existing lenders Mithra initiates monetization process, receives bridge...
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase DONESTA®...
Mithra sells shares in Mayne Pharma Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma...
Mithra updates on cash position Mithra updates on cash position Mithra's current cash of EUR 6.5 million is expected to cover its...
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel Rafa...
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients Important milestone for Mithra’s...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約